JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
|
+$1.79B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.72B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.6B |
| 4 |
Deere & Co
DE
|
+$1.34B |
| 5 |
Amazon
AMZN
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares TIPS Bond ETF
TIP
|
+$1.61B |
| 2 |
Tesla
TSLA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.51B |
| 4 |
Salesforce
CRM
|
+$1.32B |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 25.65% |
| 2 | Technology | 15.75% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Healthcare | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MTCR
3626
DELISTED
Metacrine, Inc. Common Stock
MTCR
| $1.94M | ﹤0.01% |
313,066
+240,950
| +334% | +$2.13M |
2020 Q4
1 quarter
|
|
|
SVFAU
3627
DELISTED
SVF Investment Corp. Unit
SVFAU
| $1.94M | ﹤0.01% |
+183,678
| New | +$2.31M |
2021 Q1
0 quarters
|
|
3628
Enanta Pharmaceuticals
ENTA
$377M
| $1.94M | ﹤0.01% |
39,307
-4,946
| -11% | -$247K |
2016 Q1
20 quarters
|
|
3629
iShares 10-20 Year Treasury Bond ETF
TLH
$10.3B
| $1.94M | ﹤0.01% |
13,827
-911
| -6% | -$135K |
2019 Q2
7 quarters
|
|
3630
Hudbay
HBM
$12.1B
| $1.93M | ﹤0.01% |
+280,907
| New | +$1.93M |
2021 Q1
0 quarters
|
|
|
GCACU
3631
DELISTED
Growth Capital Acquisition Corp. Unit
GCACU
| $1.93M | ﹤0.01% |
+194,751
| New | +$1.96M |
2021 Q1
0 quarters
|
|
3632
FTAI Aviation
FTAI
$17.2B
| $1.92M | ﹤0.01% |
+79,539
| New | +$1.78M |
2021 Q1
0 quarters
|
|
3633
Luxfer Holdings
LXFR
$466M
| $1.91M | ﹤0.01% |
89,888
+5,729
| +7% | +$108K |
2016 Q1
20 quarters
|
|
3634
UroGen Pharma
URGN
$2.02B
| $1.91M | ﹤0.01% |
98,157
+13,175
| +16% | +$280K |
2019 Q2
7 quarters
|
|
|
OEPWU
3635
DELISTED
One Equity Partners Open Water I Corp. Unit
OEPWU
| $1.91M | ﹤0.01% |
+191,662
| New | +$1.96M |
2021 Q1
0 quarters
|
|
3636
PJT Partners
PJT
$3.55B
| $1.91M | ﹤0.01% |
28,232
+11,509
| +69% | +$833K |
2015 Q4
21 quarters
|
|
3637
GSI Technology
GSIT
$216M
| $1.9M | ﹤0.01% |
284,117
-21,224
| -7% | -$159K |
2017 Q4
13 quarters
|
|
3638
iShares Russell Top 200 ETF
IWL
$2.25B
| $1.9M | ﹤0.01% |
20,000
| – | – |
2020 Q3
2 quarters
|
|
|
PMGMU
3639
DELISTED
Priveterra Acquisition Corp. II Unit
PMGMU
| $1.89M | ﹤0.01% |
+189,117
| New | +$1.95M |
2021 Q1
0 quarters
|
|
|
BTAQ
3640
CALL
DELISTED
Burgundy Technology Acquisition Corporation Class A Ordinary shares
BTAQ
| $1.89M | ﹤0.01% |
+191,100
| New | +$2.03M |
2021 Q1
0 quarters
|
|
3641
First Mid Bancshares
FMBH
$1.33B
| $1.89M | ﹤0.01% |
43,007
-3,160
| -7% | -$119K |
2017 Q4
13 quarters
|
|
3642
Legend Biotech
LEGN
$3.61B
| $1.89M | ﹤0.01% |
65,082
+24,519
| +60% | +$669K |
2020 Q2
3 quarters
|
|
3643
Expro Ltd
XPRO
$1.83B
| $1.89M | ﹤0.01% |
88,623
+5,724
| +7% | +$124K |
2017 Q4
13 quarters
|
|
|
HCAR
3644
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
| $1.89M | ﹤0.01% |
+195,000
| New | +$1.95M |
2021 Q1
0 quarters
|
|
|
AUD
3645
DELISTED
Audacy, Inc.
AUD
| $1.88M | ﹤0.01% |
358,831
-18,579
| -5% | -$90.3K |
2013 Q2
31 quarters
|
|
3646
PUT
Shopify
SHOP
$195B
| $1.88M | ﹤0.01% |
+17,000
| New | +$2.05M |
2021 Q1
0 quarters
|
|
|
AKUS
3647
DELISTED
Akouos Inc
AKUS
| $1.88M | ﹤0.01% |
135,470
+129,042
| +2,007% | +$2.35M |
2020 Q3
2 quarters
|
|
3648
Sotera Health
SHC
$5.2B
| $1.88M | ﹤0.01% |
75,157
+6,469
| +9% | +$171K |
2020 Q4
1 quarter
|
|
|
TVRD
3649
Tvardi Therapeutics
TVRD
$15.3M
| $1.87M | ﹤0.01% |
2,393
-344
| -13% | -$236K |
2014 Q1
28 quarters
|
|
|
DENN
3650
DELISTED
Denny's
DENN
| $1.87M | ﹤0.01% |
103,027
+18,674
| +22% | +$318K |
2017 Q4
13 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2021 Portfolio in Review
As of Q1 2021, JP Morgan Chase held 6,599 positions worth $749B, up 10% from $681B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
JP Morgan Chase deployed $36.2B of net new capital in Q1 2021, opening 866 new positions and adding to 2,869 existing holdings. Its largest new stake was Ferguson: 4,925,283 shares worth $592M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares TIPS Bond ETF, an estimated $1.61B trimmed.
- JP Morgan Chase's largest Q1 2021 buy was Ferguson: 4,925,283 shares worth $592M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF in Q1 2021, an estimated $1.79B increase.
- JP Morgan Chase's biggest Q1 2021 reduction was iShares TIPS Bond ETF, cutting an estimated $1.61B.
- JP Morgan Chase fully exited TC Pipelines LP in Q1 2021, selling an estimated $65.2M.
- JP Morgan Chase's ten largest holdings make up 15% of its $749B portfolio in Q1 2021.
- JP Morgan Chase opened 866 new positions and closed 461 in Q1 2021.
- JP Morgan Chase's portfolio value rose 10% quarter-over-quarter to $749B.
Based on JP Morgan Chase's 13F filing for Q1 2021, filed 12 May 2021.